What is the implication, and what should change now? • Our study found that EGFR mutation showed a trend toward better outcomes among oligometastatic NSCLC patients undergoing pulmonary resection as part of cLCT.
← all excerpts
Role of genetic alterations on outcomes for pulmonary resection in oligometastatic non-small cell lung cancer.
1
—
—